The Future of Glyco-therapeutics
Aviceda Therapeutics is a disruptive clinical-stage biotech company focused on the next generation of immuno-modulators by harnessing the power of glycobiology to address the innate immune system and chronic non-resolving inflammation specifically and profoundly using a propriety HALOS platform Technology.
Aviceda is developing glyco-immuno therapeutics targeting devastating ocular and systemic degenerative, fibrotic, and immuno-inflammatory diseases.
A combination of cutting-edge technologies and deep biological insights form Aviceda’s engine of transformative product creation. Aviceda has combined the power of our glycobiology and glycochemistry platform with our proprietary nanoparticle technology (HALOS) to engineer transformative disease modifying medicines.
Using our cell-based high-throughput screening (HTS) platform, we can rapidly screen, select, and optimize ligands based on maximum affinity and specificity for each different type of innate immune cell. Optimized ligands are tethered to our modular biodegradable nanoparticles using high precision conjugation chemistry to form biologically stable linkages.
Our GCT nanoparticles are designed for optimal therapeutic durability and maximum therapeutic efficacy while utilizing the most effective route of administration.
Aviceda’s platform is highly adaptable, enabling the development of a broad spectrum of therapeutics for immuno-inflammatory indications with large unmet medical needs.
Company Details
- Employees
- 39
- Founded
- -
- Address
- One Broadway, 14th Floor,united States
- Phone
- 617-332-0741
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- avicedarx.com
- HQ
- Cambridge, Massachusetts
Aviceda Therapeutics Questions
Aviceda Therapeutics's helpline number is 617-332-0741
Aviceda Therapeutics's website is avicedarx.com
Aviceda Therapeutics's LinkedIn profile is https://www.linkedin.com/company/aviceda-therapeutics
Aviceda Therapeutics has
39 employees.
View email and phone details for 39
employees at Aviceda Therapeutics.
Aviceda Therapeutics's industry is
Biotechnology Research
Aviceda Therapeutics's top competitors are
Marengo Therapeutics,
Qld Biotherapeutics Inc,
Incendia Therapeutics,
Seaport Therapeutics,
Vivtex,
1910 Genetics,
Pledge Therapeutics,
Manifold Bio,
Kytopen,
Nona Biosciences.
Aviceda Therapeutics's categories are Biotechnology Research
Aviceda Therapeutics's founding year is 2018
